tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Halozyme Therapeutics (GB:0J2O)
:0J2O
UK Market
0J2O
Halozyme
Overview
Analyst Forecasts
Dividends
Earnings
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Halozyme (0J2O) Stock News & Sentiment

Compare
1 Followers
Optimistic Buy Rating for Halozyme Amid Price Control Concerns
Premium
Ratings
Optimistic Buy Rating for Halozyme Amid Price Control Concerns
14d ago
HALO
Hold Rating Issued Amid Uncertainty in Drug Pricing Regulations Impacting Halozyme
Premium
Ratings
Hold Rating Issued Amid Uncertainty in Drug Pricing Regulations Impacting Halozyme
15d ago
HALO
Cautious Optimism for Halozyme Amid Uncertainties: Hold Rating Maintained
Premium
Ratings
Cautious Optimism for Halozyme Amid Uncertainties: Hold Rating Maintained
21d ago
HALO
Halozyme Therapeutics Reports Strong Earnings and Growth
Premium
Company Announcements
Halozyme Therapeutics Reports Strong Earnings and Growth
21d ago
HALO
Halozyme’s Strong Financial Performance and Strategic Developments Justify Buy Rating with $75 Price Target
Premium
Ratings
Halozyme’s Strong Financial Performance and Strategic Developments Justify Buy Rating with $75 Price Target
21d ago
HALO
Buy Rating for Halozyme Amid Legal Battle with Merck: Potential Multi-Billion-Dollar Royalty Opportunity
Premium
Ratings
Buy Rating for Halozyme Amid Legal Battle with Merck: Potential Multi-Billion-Dollar Royalty Opportunity
21d ago
HALO
Halozyme’s Strong Financial Performance and Strategic Initiatives Drive Buy Rating
Premium
Ratings
Halozyme’s Strong Financial Performance and Strategic Initiatives Drive Buy Rating
22d ago
HALO
More GB:0J2O News >

0J2O News on the Web

Bayer Gets CHMP Nod for Eylea 8 mg in the EU for 2 Major Eye Diseases
Zacks
Neutral
Bayer Begins Phase I Study on BAY 3670549 in Atrial Fibrillation
Zacks
Neutral
ARMP Soars 72% in a Month Following Infectious Disease Study Success
Zacks
Bullish
CRISPR Therapeutics Inks Collaboration Deal to Develop siRNA Therapies
Zacks
Neutral
REGN Signs $256M Buyout Deal With 23andMe to Boost Genomics Research
Zacks
Neutral
ACAD Stock Soars as US Court Rules in Favor of Key Nuplazid Patent
Zacks
Neutral
Incyte Gets FDA Approval for Zynyz in New Cancer Indication
Zacks
Neutral
Why Halozyme Therapeutics, Inc.amp;#8217;s (HALO) Stock Is Up 5.32%
AAII
Neutral

News Score - Last 7 Days

Neutral
GB:0J2O
Sector Average
Media Buzz
This Week6 articles
Weekly Average6.75 articles
News Sentiment
This Week59%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GB:0J2O’s Media Buzz Sentiment?
6 articles about GB:0J2O were published this week. In an average week, 6.75 articles are published.
    What is GB:0J2O’s weekly average amount of articles?
    In an average week, 6.75 articles about GB:0J2O are published.
      What is GB:0J2O’s News Sentiment?
      59% of articles about GB:0J2O were positive this week, compared to its sector average of 56%.
        Healthcare Stocks that are Trending in the News
        PAHCPhibro Animal Health
        PBHPrestige Consumer Healthcare
        PHRPhreesia
        THCTenet Healthcare
        AJ91DocCheck AG
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing